|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
National Lung Screening Trial Research
Team, ; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD,
Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM and Sicks JD:
Reduced lung-cancer mortality with low-dose computed tomographic
screening. N Engl J Med. 365:395–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G,
Garg K, et al: International association for the study of lung
Cancer/American thoracic Society/European respiratory society
international multidisciplinary classification of lung
adenocarcinoma. Proc Am Thorac Soc. 8:381–385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noguchi M: Stepwise progression of
pulmonary adenocarcinoma-clinical and molecular implications.
Cancer Metastasis Rev. 29:15–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scott WJ, Howington J, Feigenberg S,
Movsas B and Pisters K; American College of Chest Physicians, :
Treatment of non-small cell lung cancer stage I and stage II: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132 (3 Suppl):234S–242S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Campbell I, Polyak K and Haviv I: Clonal
mutations in the cancer-associated fibroblasts: The case against
genetic coevolution. Cancer Res. 69:6765–6768. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ishii G, Ochiai A and Neri S: Phenotypic
and functional heterogeneity of cancer-associated fibroblast within
the tumor microenvironment. Adv Drug Deliv Rev. 99:186–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feig C, Jones JO, Kraman M, Wells RJ,
Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL,
et al: Targeting CXCL12 from FAP-expressing carcinoma-associated
fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic
cancer. Proc Natl Acad Sci USA. 110:20212–20217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution. Curr
Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ito M, Ishii G, Nagai K, Maeda R, Nakano Y
and Ochiai A: Prognostic impact of cancer-associated stromal cells
in patients with stage I lung adenocarcinoma. Chest. 142:151–158.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawase A, Ishii G, Nagai K, Ito T, Nagano
T, Murata Y, Hishida T, Nishimura M, Yoshida J, Suzuki K and Ochiai
A: Podoplanin expression by cancer associated fibroblasts predicts
poor prognosis of lung adenocarcinoma. Int J Cancer. 123:1053–1059.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vandooren J, Van den Steen PE and
Opdenakker G: Biochemistry and molecular biology of gelatinase B or
matrix metalloproteinase-9 (MMP-9): The next decade. Crit Rev
Biochem Mol Biol. 48:222–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH,
Klenotic PA, Cutler A, Asosingh K, Erzurum S and Anand-Apte B:
Cross-talk between vascular endothelial growth factor and matrix
metalloproteinases in the induction of neovascularization in vivo.
Am J Pathol. 176:496–503. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mira E, Lacalle RA, Buesa JM, de Buitrago
GG, Jiménez-Baranda S, Gómez-Moutón C, Martínez-A C and Mañes S:
Secreted MMP9 promotes angiogenesis more efficiently than
constitutive active MMP9 bound to the tumor cell surface. J Cell
Sci. 117:1847–1857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai J, Li R, Xu X, Zhang L, Wu S, Yang T,
Fang L, Wu J, Zhu X, Li M and Huang Y: URGCP promotes non-small
cell lung cancer invasiveness by activating the NF-κB-MMP-9
pathway. Oncotarget. 6:36489–36504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stacker SA, Achen MG, Jussila L, Baldwin
ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev
Cancer. 2:573–583. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kadota K, Huang CL, Liu D, Ueno M, Kushida
Y, Haba R and Yokomise H: The clinical significance of
lymphangiogenesis and angiogenesis in non-small cell lung cancer
patients. Eur J Cancer. 44:1057–1067. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iwakiri S, Nagai S, Katakura H, Takenaka
K, Date H, Wada H and Tanaka F: D2-40-positive lymphatic vessel
density is a poor prognostic factor in squamous cell carcinoma of
the lung. Ann Surg Oncol. 16:1678–1685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: WHO Classification of Tumours of the Lung,
Pleura, Thymus and Heart. 4th. Lyon, France: IARC Press; 2015
|
|
24
|
Hashimoto O, Yoshida M, Koma Y, Yanai T,
Hasegawa D, Kosaka Y, Nishimura N and Yokozaki H: Collaboration of
cancer-associated fibroblasts and tumour-associated macrophages for
neuroblastoma development. J Pathol. 240:211–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ikemura S, Aramaki N, Fujii S, Kirita K,
Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, et al:
Changes in the tumor microenvironment during lymphatic metastasis
of lung squamous cell carcinoma. Cancer Sci. 108:136–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu JM, Liu K, Liu JH, Jiang XL, Wang XL,
Chen YZ, Li SG, Zou H, Pang LJ, Liu CX, et al: CD163 as a marker of
M2 macrophage, contribute to predicte aggressiveness and prognosis
of Kazakh esophageal squamous cell carcinoma. Oncotarget.
8:21526–21538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu YL, Hung JY, Chiang SY, Jian SF, Wu
CY, Lin YS, Tsai YM, Chou SH, Tsai MJ and Kuo PL: Lung
cancer-derived galectin-1 contributes to cancer associated
fibroblast-mediated cancer progression and immune suppression
through TDO2/kynurenine axis. Oncotarget. 7:27584–27598. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Otomo R, Otsubo C, Matsushima-Hibiya Y,
Miyazaki M, Tashiro F, Ichikawa H, Kohno T, Ochiya T, Yokota J,
Nakagama H, et al: TSPAN12 is a critical factor for
cancer-fibroblast cell contact-mediated cancer invasion. Proc Natl
Acad Sci USA. 111:18691–18696. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matsubara D, Morikawa T, Goto A, Nakajima
J, Fukayama M and Niki T: Subepithelial myofibroblast in lung
adenocarcinoma: A histological indicator of excellent prognosis.
Mod Pathol. 22:776–785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kodate M, Kasai T, Hashimoto H, Yasumoto
K, Iwata Y and Manabe H: Expression of matrix metalloproteinase
(gelatinase) in T1 adenocarcinoma of the lung. Pathol Int.
47:461–469. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanomata N, Nakahara R, Oda T, Aoyagi Y,
Ishii G, Yokose T, Hasebe T, Nagai K, Yokozaki H and Ochiai A:
Expression and localization of mRNAs for matrix metalloproteinases
and their inhibitors in mixed bronchioloalveolar carcinomas with
invasive components. Mod Pathol. 18:828–837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taguchi A, Kawana K, Tomio K, Yamashita A,
Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, Kojima S, et al:
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts
(CAFs) is suppressed by omega-3 polyunsaturated fatty acids in
vitro and in vivo. PLoS One. 9:e896052014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei R, Lv M, Li F, Cheng T, Zhang Z, Jiang
G, Zhou Y, Gao R, Wei X and Lou J: Human CAFs promote
lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling
axis. Oncotarget. 8:67315–67328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin NN, Wang P, Zhao D, Zhang FJ, Yang K
and Chen R: Significance of oral cancer-associated fibroblasts in
angiogenesis, lymphangiogenesis, and tumor invasion in oral
squamous cell carcinoma. J Oral Pathol Med. 46:21–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu QW, Yang QM, Huang YF, She HQ, Liang J,
Yang QL and Zhang ZM: Expression and clinical significance of
matrix metalloproteinase-9 in lymphatic invasiveness and metastasis
of breast cancer. PLoS One. 9:e978042014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cirri P and Chiarugi P: Cancer associated
fibroblasts: The dark side of the coin. Am J Cancer Res. 1:482–497.
2011.PubMed/NCBI
|
|
37
|
Chen L, Qin Y, Zhang T, Ding N, Chen Y,
Zhang Z and Guo C: Clinical significance of cancer-associated
fibroblasts and their correlation with microvessel and lymphatic
vessel density in lung adenocarcinoma. J Clin Lab Anal.
33:e228322019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshizawa A, Motoi N, Riely GJ, Sima CS,
Gerald WL, Kris MG, Park BJ, Rusch VW and Travis WD: Impact of
proposed IASLC/ATS/ERS classification of lung adenocarcinoma:
Prognostic subgroups and implications for further revision of
staging based on analysis of 514 stage I cases. Mod Pathol.
24:653–664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ujiie H, Kadota K, Chaft JE, Buitrago D,
Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, et al:
Solid predominant histologic subtype in resected stage I lung
adenocarcinoma is an independent predictor of early, extrathoracic,
multisite recurrence and of poor postrecurrence survival. J Clin
Oncol. 33:2877–2884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yanagawa N, Shiono S, Abiko M, Katahira M,
Osakabe M and Ogata SY: The Clinical impact of solid and
micropapillary patterns in resected lung adenocarcinoma. J Thorac
Oncol. 11:1976–1983. 2016. View Article : Google Scholar : PubMed/NCBI
|
